CDT1

protein-coding

chromatin licensing and DNA replication factor 1

Gene summary

The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]

MANE transcript

NM_030928.4

Inheritance

AR, AD

ClinVar variants

P:26U:247B:159

Top phenotype

Meier-Gorlin syndrome 4

gnomAD constraint

pLI —, LoF o/e 0.81

Max pathogenic AF

—

Genomic locus

chr16:88,803,789-88,809,258

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~5.5 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Meier-Gorlin syndrome 4DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013431

Submitter: ClinGen

The CDT1 gene is located on chromosome 16 at 16q24.3 and encodes the chromatin licensing and DNA replication factor 1, a ubiquitously expressed protein which is required for pre-replication complex assembly. The CDT1 cooperates with the origin recognition complex (ORC) and CDC6 in recruiting mini-chromosome maintenance (MCM) complex to DNA to form pre-replication complexes and is also implicated in mitosis. The CDT1 gene was first reported in relation to autosomal recessive Meier-Gorlin syndrome 4 (MGS4) in 2011 (Bicknell et al. 2011 PMID 21358632; Guernsey et al. 2011 PMID 21358631). Meier-Gorlin syndrome (MGS) is characterized by a clinical triad of symptoms: short stature, microtia, and small or absent patellae. Additional features reported in individuals with MGS4 may include IUGR with failure to thrive, reduced body weight, respiratory issues, pulmonary emphysema, abnormal genitalia in males and mammary hypoplasia in females, musculoskeletal abnormalities, and dysmorphic facial features with small mouth, microretrognathia, and full lips, among other presentations (22333897: de Munnik et al. 2012). Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least nine unique variants have been found in either compound heterozygous (n=7) or homozygous (n=1) state in eight cases diagnosed with MGS from five reports in the literature (21358631; 21358632; Munnik et al., 2012 PMID 22333897; Kim et al. 2017 PMID 28425089; Knapp et al. 2020 PMID 33338304). These included four unique missense variants (one of which is is predicted to impact splicing), two nonsense variants, one frameshift variant, one intronic variant shown to affect splicing, and one in frame indel (removing 1 amino acid) variant. More genetic evidence has been reported in the literature but was not scorable according to the current guidelines (21358632; 28425089; Fitzgerald et al. 2015 PMID 25533962; Retterer et al. 2016 PMID 26633542). Experimental evidence includes data on biochemical function, functional alteration and a non-human model organism. A number of genes involved in pre-replication complex formation and function have been associated with Meier-Gorlin syndrome (MGS). Specifically, ORC1, ORC4, ORC6, CDC6, CDC45, MGM5, GMNN, and DONSON have all been associated with autosomal recessive MGS (33477564: Schmit and Bielinsky 2021). Patient-derived lymphoblastoid cell lines show impaired origin licensing capacity as shown through reduced episome replication (Stiff et al. 2013 PMID 23516378). Several biallelic Dup (CDT1-ortholog) loss-of-function Drosophila mutants are either embryonically lethal with some mutants showing a block in replication early in S phase, or present with defect in replication in ovaries of adult females (Whittaker et al. 2000 PMID 10898791). In summary, there is definitive evidence to support the relationship between CDT1 and autosomal recessive Meier-Gorlin syndrome 4. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.

Meier-Gorlin syndrome 4STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013431

Submitter: Labcorp Genetics (formerly Invitae)

Meier-Gorlin syndrome 4DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013431

Submitter: G2P

Meier-Gorlin syndromeSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0016817

Submitter: Orphanet

Clinical Genomic Database (CGD)

Meier-Gorlin syndrome 4AR

Manifestation: Craniofacial; Endocrine; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 11477602; 11992493; 21358631Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CDT1 variants in ClinVar

7 Conditions Cataloged
not providedTotal: 407
Inborn genetic diseasesTotal: 163
not specifiedTotal: 71
Meier-Gorlin syndrome 4Total: 28
CDT1-related disorderTotal: 19
Meier-Gorlin syndromeTotal: 1
Adenine phosphoribosyltransferase deficiencyTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_030928.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
122
clinvar
4
clinvar
128
missense
2
clinvar
2
clinvar
239
clinvar
30
clinvar
3
clinvar
276
nonsense
6
clinvar
2
clinvar
1
clinvar
9
start loss
2
clinvar
2
frameshift
9
clinvar
2
clinvar
11
splice donor/acceptor (+/-2bp)
3
clinvar
3
clinvar
6
Total1792471527432

Highest pathogenic variant AF is 0.00011347599

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 7 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_030928.4RefSeqNP_112190.210MANE Select
ENST00000301019.9EnsemblENSP00000301019.410MANE Select
ENST00000569140.1EnsemblENSP00000456926.15Standard
ENST00000929785.1EnsemblENSP00000599844.110Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
cdt1Danio rerio

Structure: cell

Quality: increased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Mitotic G1-G1-S phases
  • Retinoblastoma (RB) in Cancer
  • DNA Replication
  • cdk regulation of dna replication
  • Activation of E2F1 target genes at G1/S

Biological Process

  • DNA replication checkpoint
  • G1/S transition of mitotic cell cycle
  • regulation of transcription involved in G1/S transition of mitotic cell cycle
  • mitotic cell cycle
  • mitotic cytokinesis

Molecular Function

  • DNA binding
  • chromatin binding
  • protein binding
  • DNA polymerase binding

Cellular Component

  • kinetochore
  • condensed chromosome kinetochore
  • nucleus
  • nucleoplasm
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000301019
Coding exons
10
Length
6046
Individuals with no LoFs
125422
Homozygous LoFs
0
Heterozygous LoFs
65
Defined
125487
p
0.000259
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-1.904353371.290.00002453425
Missense (PolyPhen)8678.5921.0943799
Synonymous-2.811901471.300.00001051190
Loss of Function0.8061721.00.8100.00000109229

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000640.00056rare
Latino/Admixed American0.0000880.000087rare
Ashkenazi Jewish00.0absent
East Asian0.000170.00016rare
Finnish0.000510.00051rare
European (Non-Finnish)0.000210.00020rare
South Asian0.000690.00049rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Required for both DNA replication and mitosis (PubMed:11125146, PubMed:22581055, PubMed:21856198, PubMed:14993212, PubMed:26842564). DNA replication licensing factor, required for pre-replication complex assembly. Cooperates with CDC6 and the origin recognition complex (ORC) during G1 phase of the cell cycle to promote the loading of the mini-chromosome maintenance (MCM) complex onto DNA to generate pre-replication complexes (pre-RC)(PubMed:14672932). Required also for mitosis by promoting stable kinetochore-microtubule attachments (PubMed:22581055). Potential oncogene (By similarity). {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22581055, ECO:0000269|PubMed:26842564}.;
Disease
DISEASE: Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]: A syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal. {ECO:0000269|PubMed:21358631, ECO:0000269|PubMed:21358632}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.149

Intolerance Scores

LoFtool
0.757
RVIS EVS
1.18
RVIS percentile EVS
92.84

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.860

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.